source
- Sun Pharma to acquire Organon for $11.75 billion in all-cash dealIndian pharmaceutical company Sun Pharma announced it will purchase Organon, a company focused on women's health and biosimilars that was spun out of Merck in 2021. The transaction is an all-cash…
- Intellia reports positive Phase 3 readout for CRISPR gene-editing therapy in hereditary angioedemaIntellia Therapeutics announced that its CRISPR-based therapy achieved a successful readout in a Phase 3 trial for hereditary angioedema, a rare condition marked by sudden, potentially dangerous sw…